Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 0591-3540

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 0591-3540). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical Structure (Image 1)
Chemical structure of bupropion hydrochloride, showing its molecular framework including a chlorophenyl ring and tert-butyl group adjacent to the carbonyl and amine functional groups.*
FDA Label Image

Ndc 0591-3540-60 Twice-a-day (after Initial Titration) Bupropion HCl Extended-release Tablets, Usp (sr) 100 mg* (Image 2)

Ndc 0591-3540-60 Twice-a-day (after Initial Titration) Bupropion HCl Extended-release Tablets, Usp (sr) 100 mg* (Image 2)
Label for Bupropion Hydrochloride SR 100 mg extended-release tablets by Actavis Pharma, Inc., containing 60 film-coated oral tablets. The label includes dosing instructions, storage conditions, and a warning against use with Zyban or other bupropion products. Manufactured for Teva Pharmaceuticals.*
FDA Label Image

Ndc 0591-3541-60 Twice-a-day (after Initial Titration) Bupropion HCl Extended-release Tablets, Usp (sr) 150 mg* (Image 3)

Ndc 0591-3541-60 Twice-a-day (after Initial Titration) Bupropion HCl Extended-release Tablets, Usp (sr) 150 mg* (Image 3)
Label for Bupropion Hydrochloride SR Extended-Release Tablets, USP (SR) 150 mg produced by Actavis Pharma, Inc. The label specifies 60 film-coated tablets for oral use with the instruction to dispense a medication guide. It includes a warning against use with Zyban or other bupropion medicines and storage conditions.*
FDA Label Image

Ndc 0591-3542-60 Twice-a-day (after Initial Titration) Bupropion HCl Extended-release Tablets, Usp (sr) 200 mg* (Image 4)

Ndc 0591-3542-60 Twice-a-day (after Initial Titration) Bupropion HCl Extended-release Tablets, Usp (sr) 200 mg* (Image 4)
Label for Bupropion Hydrochloride SR extended-release tablets, USP, 200 mg strength. The label states it is for oral route with a twice-a-day dosing after initial titration. It includes warnings about not using with Zyban or other bupropion products and notes the labeler as Actavis Pharma, Inc. The package contains 60 tablets and displays storage instructions and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.